Cargando…

Can a Synbiotic Supplementation Contribute to Decreasing Anti-Tissue Transglutaminase Levels in Children with Potential Celiac Disease?

PURPOSE: Synbiotics can alleviate some intestinal pathologies or prevent trigger mechanisms for some diseases such as celiac disease (CD). If patients with high levels of anti-tissue transglutaminase (anti-tTG) immunoglobulin A (IgA) antibodies have normal duodenal histology, they are followed as po...

Descripción completa

Detalles Bibliográficos
Autor principal:	Demiroren, Kaan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354869/ https://www.ncbi.nlm.nih.gov/pubmed/32704500 http://dx.doi.org/10.5223/pghn.2020.23.4.397

Ejemplares similares

Possible relationship between refractory celiac disease and malignancies
por: Demiroren, Kaan
Publicado: (2022)

Effect of helicobacter pylori infection eradication on serum level of anti-tissue transglutaminase in children with celiac disease
por: Rohani, Pejman, et al.
Publicado: (2023)

Celiac disease can be predicted by high levels of tissue transglutaminase antibodies in children and adolescents with type 1 diabetes
por: Cerqueiro Bybrant, Mara, et al.
Publicado: (2020)

Mucosal tissue transglutaminase expression in celiac disease
por: Villanacci, Vincenzo, et al.
Publicado: (2009)

Tissue Transglutaminase but Not Microbial Transglutaminase Is Inhibited by Exogenous Oxidative Substances in Celiac Disease
por: Stricker, Sebastian, et al.
Publicado: (2022)

Circulating anti-hypothalamus antibodies in celiac patients: tissue transglutaminase friend or foe?
por: Iervasi, Erika, et al.
Publicado: (2023)

Intestinal Anti-tissue Transglutaminase2 Autoantibodies: Pathogenic and Clinical Implications for Celiac Disease
por: Maglio, Mariantonia, et al.
Publicado: (2020)

Specificity of Tissue Transglutaminase Explains Cereal Toxicity in Celiac Disease
por: Vader, L. Willemijn, et al.
Publicado: (2002)

Serum and salivary tissue transglutaminase IGA (tTG-IGA) level in celiac patients
por: Ajdani, Mehran, et al.
Publicado: (2022)

Association of Tissue Transglutaminase Antibody Titer with Duodenal Histological Changes in Children with Celiac Disease
por: Hawamdeh, Hasan, et al.
Publicado: (2016)

Relationship of citrulline and tissue transglutaminase antibody with duodenal histopathology among children with celiac disease()
por: Rahmani, Parisa, et al.
Publicado: (2022)

Erratum to “Association of Tissue Transglutaminase Antibody Titer with Duodenal Histological Changes in Children with Celiac Disease”
por: Hawamdeh, Hasan, et al.
Publicado: (2019)

Intestinal Production of Anti-Tissue Transglutaminase 2 Antibodies in Patients with Diagnosis Other Than Celiac Disease
por: Maglio, Mariantonia, et al.
Publicado: (2017)

The Production of the Oral Mucosa of Antiendomysial and Anti—Tissue-Transglutaminase Antibodies in Patients with Celiac Disease: A Review
por: Compilato, Domenico, et al.
Publicado: (2010)

Association of Anti-tissue Transglutaminase Antibody Titers and Duodenal Biopsy Findings in Pediatric Patients of Celiac Disease
por: Taneja, Kanchan, et al.
Publicado: (2021)

Variability of anti-human transglutaminase testing in celiac disease across Mediterranean countries
por: Smarrazzo, Andrea, et al.
Publicado: (2017)

Microbial Transglutaminase Is Immunogenic and Potentially Pathogenic in Pediatric Celiac Disease
por: Torsten, Matthias, et al.
Publicado: (2018)

Tissue Transglutaminase Antibody and Its Association with Duodenal Biopsy in Diagnosis of Pediatric Celiac Disease
por: Meena, Daleep K., et al.
Publicado: (2019)

Injection of prototypic celiac anti-transglutaminase 2 antibodies in mice does not cause enteropathy
por: Lindstad, Christian B., et al.
Publicado: (2022)

Role of anti-tissue transglutaminase IgA+IgG antibodies in detection of potential celiac disease in patients with type 1 diabetes
por: Kaur, Navchetan, et al.
Publicado: (2019)

Maternal celiac disease autoantibodies bind directly to syncytiotrophoblast and inhibit placental tissue transglutaminase activity
por: Anjum, Naheed, et al.
Publicado: (2009)

Synbiotic supplementation to decrease Salmonella colonization in the intestine and carcass contamination in broiler birds
por: Shanmugasundaram, R., et al.
Publicado: (2019)

Microbial transglutaminase should be considered as an environmental inducer of celiac disease
por: Lerner, Aaron, et al.
Publicado: (2019)

Beneficial effects of gluten free diet on IgA tissue transglutaminase levels and various growth parameters in celiac disease patients
por: Hota, Dayanand, et al.
Publicado: (2019)

Identification of celiac disease associated IgA nephropathy by IgA anti-tissue transglutaminase2 antibody deposits in archived formalin-fixed tissues
por: Dutta, Rimlee, et al.
Publicado: (2022)

Celiac disease in patients with type-1 diabetes mellitus screened by tissue transglutaminase antibodies in northwest of Iran
por: Sharifi, Nasrin, et al.
Publicado: (2008)

Clinical Value of Tissue Transglutaminase Antibodies in Celiac Patients over a Long Term Follow-Up
por: Farina, Elisa, et al.
Publicado: (2021)

Celiac Disease-Type Tissue Transglutaminase Autoantibody Deposits in Kidney Biopsies of Patients with IgA Nephropathy
por: Nurmi, Rakel, et al.
Publicado: (2021)

A Case Series of Ingested Open Safety Pin Removal Using a Proposed Endoscopic Removal Technique Algorithm
por: Demiroren, Kaan
Publicado: (2019)

Management of Gastrointestinal Foreign Bodies with Brief Review of the Guidelines
por: Demiroren, Kaan
Publicado: (2023)

Tissue Transglutaminase Does Not Contribute to the Formation of Mutant Huntingtin Aggregates
por: Chun, Wanjoo, et al.
Publicado: (2001)

Towards Celiac-safe foods: Decreasing the affinity of transglutaminase 2 for gliadin by addition of ascorbyl palmitate and ZnCl(2) as detoxifiers
por: Engstrom, N., et al.
Publicado: (2017)

Features of ZED1227: The First-In-Class Tissue Transglutaminase Inhibitor Undergoing Clinical Evaluation for the Treatment of Celiac Disease
por: Büchold, Christian, et al.
Publicado: (2022)

Celiac Anti-Type 2 Transglutaminase Antibodies Induce Phosphoproteome Modification in Intestinal Epithelial Caco-2 Cells
por: Paolella, Gaetana, et al.
Publicado: (2013)

Adherence to dietary treatment and clinical factors associated with anti-transglutaminase antibodies in celiac disease during the follow-up
por: Miró, Marta, et al.
Publicado: (2021)

Effect of synbiotic supplementation on children with atopic dermatitis: an observational prospective study
por: Ibáñez, M. Dolores, et al.
Publicado: (2018)

Structural Basis for Antigen Recognition by Transglutaminase 2-specific Autoantibodies in Celiac Disease
por: Chen, Xi, et al.
Publicado: (2015)

B cell tolerance and antibody production to the celiac disease autoantigen transglutaminase 2
por: du Pré, M. Fleur, et al.
Publicado: (2019)

Antibody Responses to Transglutaminase 3 in Dermatitis Herpetiformis: Lessons from Celiac Disease
por: Kaunisto, Helka, et al.
Publicado: (2022)

Utility of Tissue Transglutaminase Immunohistochemistry in Pediatric Duodenal Biopsies: Patterns of Expression and Role in Celiac Disease—A Clinicopathologic Review
por: Almarzooqi, Saeeda, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_1gt3h0dr9gembka2pdrchpsf36